
Alternative cancer treatment could replace chemo and surgery, study suggests
New cancer research pioneered by Memorial Sloan Kettering points to a strong alternative to chemotherapy, surgery and radiation for some forms of cancer.
Nearly 80% of patients who suffered from a variety of cancer types were successfully treated with only immunotherapy, according to a new study published in The New England Journal of Medicine.
The immunotherapy protocol successfully treated 100% of rectal cancer patients involved in the trial.
"My husband, Tommy, and I were preparing for the worst," recalled Maureen Sideris, who was diagnosed with gastroesophageal junction cancer in 2022 and subsequently became a participant in the trial.
"After being treated with only immunotherapy, I had no evidence of cancer and didn't have to undergo surgery, chemo or radiation," she said in an MSK press release. "I felt like I won the lottery!"
Dr. Andrea Cercek, a gastrointestinal oncologist, oversaw the research along with fellow gastrointestinal oncologist Dr. Luiz Diaz.
The pair sought to develop this approach in part due to the negative impacts of traditional treatment, according to the release.
"Using the standard-of-care treatment of surgery, radiation and chemotherapy to treat rectal cancer is effective," Cercek said.
"But the treatments can leave people infertile and severely affect bowel, urinary and sexual functions, as well as other aspects of daily life."
"After being treated with only immunotherapy, I had no evidence of cancer and didn't have to undergo surgery, chemo or radiation."
Participants in the trial were all patients with tumors ranging from stage 1 to stage 3, meaning the tumors had not yet spread, the release indicated.
The tumors also had a genetic mutation called mismatch repair-deficient (MMRd), which makes them particularly vulnerable to a type of immunotherapy called "checkpoint inhibitors."
This therapy "unmasks" tumor cells, MSK stated, making it easier for the patient's own immune system to recognize and kill cancer cells.
The first clinical trial testing the therapy started with only 18 patients, all of whom had rectal cancer.
"We knew there was a broad range of cancer types that had this same MMRd genetic mutation," Cercek said. "We hoped this approach could help people facing these other cancers, too."
In the expanded trial, which contained 103 patients, there were 49 rectal cancer patients and 54 patients with other types of cancer. Participants received checkpoint inhibitor infusions intravenously over the course of six months, per the release.
In all 49 rectal cancer patients, there was no evidence of cancer after immunotherapy.
Of the 54 patients with other cancers, 35 saw all signs of cancer disappear after therapy, according to a variety of tests performed for the study.
"This is a very significant response, and the results were even better than we had hoped," said Cercek. "We found that some cancer types responded extremely well to the immunotherapy, including colon and stomach cancer."
In the 20% of non-rectal cancer patients who still needed surgery post-therapy, researchers saw that the immunotherapy often shrunk the tumor and even lowered the stage classifications of some of the tumors, according to Cercek.
Timothy Yap, Ph.D., a medical oncologist at the University of Texas MD Anderson Cancer Center, agrees that the immunotherapy treatment's effectiveness for multiple kinds of cancer is "exciting."
"We are always seeking to improve treatment strategies for cancer patients through innovative clinical trials, and this is no exception," Yap, who was not involved in the study, told Fox Digital.
"Responding patients may avoid the need for surgery, chemotherapy and radiation therapy, and benefit by improving their quality of life," he said.
"This is a very significant response, and the results were even better than we had hoped."
Based on the results of the original trial with rectal patients, the immunotherapy-only approach has been incorporated into the treatment guidelines of the National Comprehensive Cancer Network, which is the doctor's group that sets cancer treatments in the U.S., the release stated.
For more Health articles, visit www.foxnews.com/health
Some of the original participants of the 2022 trial are still cancer-free today, multiple years after the initial treatment.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New York Times
11 hours ago
- New York Times
Rare Appendix Cancers Are Increasing Among Millennials and Gen X
A new study shows that appendix cancer is becoming more common among younger generations, mirroring a pattern that has been occurring with other cancers since the 1990s. Cancer incidence rates among members of Generation X were two to three times higher than among people born in the 1940s, according to the study, which was published Monday in the Annals of Internal Medicine. Rates among older millennials, born in the 1980s, were more than four times higher. Even with those increases, appendix cancer still remains extremely rare. Doctors diagnose an estimated 3,000 new cases in the United States each year, compared with more than 150,000 cases of colon and rectal cancers. The findings come at a time of growing concern about the earlier onset of certain cancers, including colorectal, breast and kidney cancers. The new research describes what's known as a 'birth cohort' effect, or a disease becoming more common among successive generations. Such an effect lends credence to the idea that people born after a certain time have had similar exposures to something that is increasing their cancer risk more so than among people born decades before, said Dr. Andrea Cercek, a medical oncologist at Memorial Sloan Kettering Cancer Center who was not involved in the study. And the fact that researchers have seen similar generational effects in colorectal and gastric cancers suggests there may be some shared risk factors between those cancers and appendix cancer, said Dr. Andrew T. Chan, a gastroenterologist and professor of medicine at Harvard Medical School who researches the epidemiology of colon cancer and also was not involved in the study. Diet is one such possibility, he said. Our consumption of ultraprocessed foods has increased over time, and these foods — particularly processed meats and sugar-sweetened beverages — have been associated with increased risk for colon cancer. Want all of The Times? Subscribe.
Yahoo
a day ago
- Yahoo
Advertiser readers congratulate six-year-old who beat cancer
Swindon Adver readers congratulated a six-year-old boy who has officially beaten cancer. Tommy was diagnosed with Acute Lymphoblastic Leukaemia in March 2023 and can now live without fighting each day. On April 24, Tommy rang the bell at Great Western Hospital and said the magic words: "This bell is here for you to ring, while those around you cheer and sing, already you have come so far, you're stronger than you think you are, the journeys hard make no mistake, each day small steps you need to take, with love and strength to you we say, this bell will help you on your way." We shared this truly special moment and congratulated Tommy on this happy occasion. Here's what you had to say. Helen Gibson said: 'That's excellent news. Onwards and upwards now boy, you've got this.' Sarah Plimmer said: 'Congratulations, well done to you.' Antony Thomas said: 'Well done Tommy, you're an amazing boy, bless you.' Aiden Henshaw said: 'Hard as nails, well done Tommy you warrior!' Alan Lambert said: 'Well done lad.' Michelle-Jane Banaschewsky said: 'Well done little fella, what a warrior you are.' Wendy Bain said: 'Amazing, well done young man.' Sophie said: 'Awwww what an amazing brave little boy. So nice to see something positive for once.' Leanne Waite said: 'Amazing.' Tracey Scott said: 'Wonderful news, lots of love.' Natasha Evans said: 'Awwww what fantastic news little man.' Connor Robins said: 'Brilliant news for you little man!! Must be made of metal being as strong as you are.' Mandy Lane said: 'Well done. That's amazing news to hear. Very strong young man.' Brenda Harrington said: 'Well done.' Linda Johnstone said: 'Brilliant news.' Kelly Nash said: 'Amazing news little man.' Carmel Shea said: 'What an amazing little man.' Teresa Hart said: 'Fantastic news.' Carole Green said: 'Well done Tommy!' Anne Woodward said: 'Brilliant news, brave, amazing and inspirational.' Anita Renn said: 'Most amazing boy you are Tommy.' Auriel Meyrick said: 'That's wonderful news.' Caroline Henry said: 'Lovely.' Terry Smart said: 'Fantastic news Tommy. Well done GWH.' Carolyn Sarson said: 'Brilliant news.' Siobhan Catherine said: 'Well done, what a little soldier.' Russell Watts said: 'Good lad.' Christine Smith said: 'Very well done.'


CBS News
3 days ago
- CBS News
A woman's heart suddenly stopped. Two passing nurses saved her life.
Merryl Hoffman knew she was taking good care of her heart. The 63-year-old attorney didn't smoke or drink, and she was an avid hiker who used to run marathons and other distance races. In her 40s, she had been diagnosed with a leaky mitral valve and underwent surgery to repair it. Every year since, she has seen a cardiologist to check her heart and its function. The reports always came back clear. When Hoffman left her apartment on Manhattan's Upper East Side on Oct. 23, 2025, her heart was the last thing on her mind. She was saddled with her work bag and purse, hightailing it to the subway station so she could make it to work on time. That's when her memory of the day ends. Shortly into her walk, Hoffman experienced a sudden cardiac arrest. Her heart stopped beating. She collapsed to the ground. Doctors later told her it was a severe arrhythmia that could have been fatal — if not for where Hoffman fell. Hoffman had collapsed outside Memorial Sloan Kettering Cancer Center's Breast and Imaging Center, about two and a half blocks from her subway station. A patient care technician and a passing runner immediately rushed to her aid. Then, Memorial Sloan Kettering nurses Sabrina Castle and Gianna Formisano stumbled upon the scene while walking to work. "We were so shocked. When we were walking up, people were like 'Nurses, nurses!' We didn't know what we were walking into," Formisano said. "People were grabbing our coffee, taking our bags. It was out of a movie, the way that they were like 'Oh, thank God you're here.'" Sabrina Castle and Gianna Formisano outside the Memorial Sloan Kettering Cancer Center. Memorial Sloan Kettering "They absolutely saved my life" Formisano and Castle took over performing CPR, keeping Hoffman's heart manually beating. She didn't have a pulse, and she had hit her head when she collapsed. The nurses also instructed one of the other bystanders to call an ambulance. Early CPR increases survival for patients in cardiac arrest by "at least two or three fold," said Dr. Jessica Hennessey, a cardiologist at NewYork-Presbyterian/Columbia University Irving Medical Center. Early CPR means that blood flow to the brain and heart continues, preserving the health of those organs. Bystanders in a medical emergency should call 911 and immediately start CPR, Hennessey advised. CPR can be done with mouth-to-mouth or with just chest compressions, Hennessey said. After five minutes that "felt like forever," the ambulance arrived, Formisano said. Castle and Formisano helped the EMTs load Hoffman into the ambulance. Then, she was taken to NewYork-Presbyterian's cardiac care unit for further treatment. For the small crowd, the day carried on. Castle and Formisano headed to work. After a few hours, they called NewYork-Presbyterian to see if they could find out more about Hoffman's status. They went to the hospital and spoke to a nurse there. "She was like, 'You got her back. She's intubated, she's alive, you saved her life,'" Castle recalled. Hoffman was still unconscious. She told CBS News that she didn't wake up until five days after the collapse. Her family told her that she had been rushed into surgery. Doctors told her that her heart had stopped for several minutes -- and the actions of Castle, Formisano and other bystanders had saved her. "Without them, I was told, there was no doubt I would have died or been brain dead," Hoffman said. "They absolutely saved my life." Hoffman had an implantable cardioverter-defibrillator placed in her chest to prevent further cardiac arrests. The device shocks the heart if it detects an irregular heartbeat. She also began cardiac rehabilitation. Shortly after, she returned to work. Life began to get back to normal but one question was constantly at the back of her mind: Who had helped save her? A chance reunion While in cardiac rehabilitation, Hoffman found herself telling the story of the strangers who had helped her. A physiologist there overheard her talking about it and thought the story sounded familiar. His girlfriend was friends with two nurses who had helped a woman matching Hoffman's description. After some back and forth, the physiologist connected Hoffman with Castle and Formisano. The trio immediately made plans to get dinner. Hoffman's husband joined them for the meal. There, the nurses were able to fill in the gaps of the October morning when Hoffman collapsed. Sabrina Castle, Merryl Hoffman and Gianna Formisano at the site where Hoffman collapsed. Sabrina Castle and Gianna Formisano "It was very jarring, when they gave my husband and I the blow-by-blow of that morning. There were things we did not know," Hoffman said. "It was pretty incredible." Since that dinner, the women have stayed in touch. Recently, Castle and Formisano even passed Hoffman on the same block where she had collapsed. The three took a photo at the site. "We were like, 'Wow, this is really crazy,'" Formisano said. "'We're running into you on the same spot, on your way to work, on our way to work, but now you're alive and well and in a much different state than when we met you the first time.'"